Use of Freely Available and Open Source Tools for In Silico Screening in Chemical BiologyClick to copy article linkArticle link copied!
Abstract
Automated computational docking of large libraries of chemical compounds to a protein can aid in pharmaceutical drug design and gives scientists with basic computer experience a tool to help plan wet laboratory investigations when exploring the combination of chemical and pharmacological spaces. The use of open source tools to develop and select ligands for subsequent screening is outlined. A protocol leveraging the power of Open Babel and AutoDock Vina to perform file conversion, minimization, and docking implemented as a Python script is offered.
This publication is licensed for personal use by The American Chemical Society.
Preparation of Files
Screening
Example Use
Supporting Information
A straightforward protocol written in Python that depends on Open Babel being installed is available. Vina is also provided, but if an installed version is found, that is used in preference. The code is commented and will be maintained and updated through www.opendiscovery.org.uk. This material is available via the Internet at http://pubs.acs.org.
Terms & Conditions
Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: http://pubs.acs.org/page/copyright/permissions.html.
Acknowledgment
G.W.P. thanks EPSRC for a Ph.D. studentship through Warwick MOAC DTC (EP/F500378/1). P.S.G. acknowledges BBSRC (BB/1022880/1) for funding. We thank Warwick Centre for Scientific Computing (CSC) and staff for access to parallel computing clusters, P. M. Rodger (CSC and Department of Chemistry), D. Bray (Department of Chemistry), A. J. Easton (School of Life Sciences) for helpful discussions. We also thank M. Quareshy for testing the code and for providing the example results and referees for constructive feedback.
References
This article references 25 other publications.
- 1JCE staff. Computational Chemistry for the Masses. J. Chem. Educ. 1996, 73, 104.Google ScholarThere is no corresponding record for this reference.
- 2Manallack, D. T.; Chalmers, D. K.; Yuriev, E. Using the β2-Adrenoceptor for Structure-Based Drug Design J. Chem. Educ. 2010, 87, 625– 627Google ScholarThere is no corresponding record for this reference.
- 3Hopkins, A. L. Network pharmacology: the next paradigm in drug discovery Nat. Chem. Biol. 2008, 4, 682– 690Google Scholar3https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Kgs7fK&md5=03b8be3ddbcab7dc65afd17df7ee8395Network pharmacology: the next paradigm in drug discoveryHopkins, Andrew L.Nature Chemical Biology (2008), 4 (11), 682-690CODEN: NCBABT; ISSN:1552-4450. (Nature Publishing Group)A review. The dominant paradigm in drug discovery is the concept of designing maximally selective ligands to act on individual drug targets. However, many effective drugs act via modulation of multiple proteins rather than single targets. Advances in systems biol. are revealing a phenotypic robustness and a network structure that strongly suggests that exquisitely selective compds., compared with multi-target drugs, may exhibit lower than desired clin. efficacy. This new appreciation of the role of polypharmacol. has significant implications for tackling the two major sources of attrition in drug development, efficacy and toxicity. Integrating network biol. and polypharmacol. holds the promise of expanding the current opportunity space for druggable targets. However, the rational design of polypharmacol. faces considerable challenges in the need for new methods to validate target combinations and optimize multiple structure-activity relationships while maintaining drug-like properties. Advances in these areas are creating the foundation of the next paradigm in drug discovery: network pharmacol.
- 4Brown, J. B.; Okuno, Y. Systems biology and systems chemistry: new directions for drug discovery Chem. Biol. 2012, 19, 23– 28Google Scholar4https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Ggs78%253D&md5=4caefd47360f8c59ac8ae1a0389298f6Systems Biology and Systems Chemistry: New Directions for Drug DiscoveryBrown, J. B.; Okuno, YasushiChemistry & Biology (Oxford, United Kingdom) (2012), 19 (1), 23-28CODEN: CBOLE2; ISSN:1074-5521. (Elsevier Ltd.)Improvements in drug design have historically been centered around structure-based optimization of mol. specificity for a targeted protein, in an effort to reduce unintentional binding to other proteins and off-target effects. Although the "one-to-one" drug design strategy has been successful in impairing function of targets assocd. with a no. of diseases, recent reports of drug promiscuity, which are a potential source of adverse reactions in patients, make a case to refine the drug design strategy such that it includes an awareness of multiple interactions from both ligand and protein perspectives. Polypharmacol. and chem. biol. studies are amassing interaction data at rapid rates, and the integration of such data into an interpretable model requires zooming our perspective out from the single ligand-target level to the larger network-wide level. We review some of the recent developments in systems-level research for drug design and discovery, and discuss the directions that some drug design efforts are heading toward.
- 5Ortí, L.; Carbajo, R. J.; Pieper, U.; Eswar, N.; Maurer, S. M.; Rai, A. K.; Taylor, G.; Todd, M. H.; Pineda-Lucena, A.; Sali, A.; Marti-Renom, M. A. A Kernel for Open Source Drug Discovery in Tropical Diseases PLoS Neglected Trop. Dis. 2009, 3, e418 DOI: 10.1371/journal.pntd.0000418Google ScholarThere is no corresponding record for this reference.
- 6Sutch, B. T.; Romero, R. M.; Neamati, N.; Haworth, I. S. Integrated Teaching of Structure-Based Drug Design and Biopharmaceutics: A Computer-Based Approach J. Chem. Educ. 2012, 89, 45– 51Google ScholarThere is no corresponding record for this reference.
- 7Altschul, S. F.; Gish, W.; Miller, W.; Myers, E. W.; Lipman, D. J. Basic local alignment search tool J. Mol. Biol. 1990, 215, 403Google Scholar7https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXitVGmsA%253D%253D&md5=009d2323eb82f0549356880e1101db16Basic local alignment search toolAltschul, Stephen F.; Gish, Warren; Miller, Webb; Myers, Eugene W.; Lipman, David J.Journal of Molecular Biology (1990), 215 (3), 403-10CODEN: JMOBAK; ISSN:0022-2836.A new approach to rapid sequence comparison, basic local alignment search tool (BLAST), directly approximates alignments that optimize a measure of local similarity, the maximal segment pair (MSP) score. Recent math. results on the stochastic properties of MSP scores allow an anal. of the performance of this method as well as the statistical significance of alignments it generates. The basic algorithm is simple and robust; it can be implemented in a no. of ways and applied in a variety of contexts including straightforward DNA and protein sequence database searches, motif searches, gene identification searches, and in the anal. of multiple regions of similarity in long DNA sequences. In addn. to its flexibility and tractability to math. anal., BLAST is an order of magnitude faster than existing sequence comparison tools of comparable sensitivity.
- 8Ekins, S.; Waller, C. L.; Bradley, M. P.; Clark, A. M.; Williams, A. J. Four disruptive strategies for removing drug discovery bottlenecks Drug Discovery Today 2013, 18, 265– 271Google Scholar8https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s%252FotFyktw%253D%253D&md5=eeca13e5dac8f3d04976eeeefe8f46c2Four disruptive strategies for removing drug discovery bottlenecksEkins Sean; Waller Chris L; Bradley Mary P; Clark Alex M; Williams Antony JDrug discovery today (2013), 18 (5-6), 265-71 ISSN:.Drug discovery is shifting focus from industry to outside partners and, in the process, creating new bottlenecks. Technologies like high throughput screening (HTS) have moved to a larger number of academic and institutional laboratories in the USA, with little coordination or consideration of the outputs and creating a translational gap. Although there have been collaborative public-private partnerships in Europe to share pharmaceutical data, the USA has seemingly lagged behind and this may hold it back. Sharing precompetitive data and models may accelerate discovery across the board, while finding the best collaborators, mining social media and mobile approaches to open drug discovery should be evaluated in our efforts to remove drug discovery bottlenecks. We describe four strategies to rectify the current unsustainable situation.
- 9Irwin, J. J.; Shoichet, B. K.; Mysinger, M. M.; Huang, N.; Francesco Colizzi, F.; Wassam, P.; Cao, Yiqun. Automated Docking Screens: A Feasibility Study J. Med. Chem. 2009, 52, 5712– 5720Google Scholar9https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVOjurjN&md5=f302db1f77b87f26d1fa2fece55bca96Automated Docking Screens: A Feasibility StudyIrwin, John J.; Shoichet, Brian K.; Mysinger, Michael M.; Huang, Niu; Colizzi, Francesco; Wassam, Pascal; Cao, YiqunJournal of Medicinal Chemistry (2009), 52 (18), 5712-5720CODEN: JMCMAR; ISSN:0022-2623. (American Chemical Society)Mol. docking is the most practical approach to leverage protein structure for ligand discovery, but the technique retains important liabilities that make it challenging to deploy on a large scale. We have therefore created an expert system, DOCK Blaster, to investigate the feasibility of full automation. The method requires a PDB code, sometimes with a ligand structure, and from that alone can launch a full screen of large libraries. A crit. feature is self-assessment, which ests. the anticipated reliability of the automated screening results using pose fidelity and enrichment. Against common benchmarks, DOCK Blaster recapitulates the crystal ligand pose within 2 Å rmsd 50-60% of the time; inferior to an expert, but respectable. Half the time the ligand also ranked among the top 5% of 100 phys. matched decoys chosen on the fly. Further tests were undertaken culminating in a study of 7755 eligible PDB structures. In 1398 cases, the redocked ligand ranked in the top 5% of 100 property-matched decoys while also posing within 2 Å rmsd, suggesting that unsupervised prospective docking is viable. DOCK Blaster is available at http://blaster.docking.org.
- 10Gaulton, A.; Bellis, L. J.; Bento, A. P.; Chambers, J.; Davies, M.; Hersey, A.; Light, Y.; McGlinchey, S.; Michalovich, D.; Al-Lazikani, B.; Overington, J. P. ChEMBL: a large-scale bioactivity database for drug discovery Nucleic Acids Res. 2011, 40, 1100– 1107Google ScholarThere is no corresponding record for this reference.
- 11O’Boyle, N. M.; Banck, M.; James, C. A.; Morley, C.; Vandermeersch, T.; Hutchison, G. R. Open Babel: An open chemical toolbox J. Cheminf. 2011, 3, 33 DOI: 10.1186/1758-2946-3-33Google Scholar11https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVWjurbF&md5=74e4f19b7f87417f916d57f7abcfb761Open Babel: an open chemical toolboxO'Boyle, Noel M.; Banck, Michael; James, Craig A.; Morley, Chris; Vandermeersch, Tim; Hutchison, Geoffrey R.Journal of Cheminformatics (2011), 3 (), 33CODEN: JCOHB3; ISSN:1758-2946. (Chemistry Central Ltd.)Background: A frequent problem in computational modeling is the interconversion of chem. structures between different formats. While std. interchange formats exist (for example, Chem. Markup Language) and de facto stds. have arisen (for example, SMILES format), the need to interconvert formats is a continuing problem due to the multitude of different application areas for chem. data, differences in the data stored by different formats (0D vs. 3D, for example), and competition between software along with a lack of vendor-neutral formats. Results: We discuss, for the first time, Open Babel, an open-source chem. toolbox that speaks the many languages of chem. data. Open Babel version 2.3 interconverts over 110 formats. The need to represent such a wide variety of chem. and mol. data requires a library that implements a wide range of cheminformatics algorithms, from partial charge assignment and aromaticity detection, to bond order perception and canonicalization. We detail the implementation of Open Babel, describe key advances in the 2.3 release, and outline a variety of uses both in terms of software products and scientific research, including applications far beyond simple format interconversion. Conclusions: Open Babel presents a soln. to the proliferation of multiple chem. file formats. In addn., it provides a variety of useful utilities from conformer searching and 2D depiction, to filtering, batch conversion, and substructure and similarity searching. For developers, it can be used as a programming library to handle chem. data in areas such as org. chem., drug design, materials science, and computational chem. It is freely available under an open-source license.
- 12The Open Babel Package, version 2.3.1. http://openbabel.org (accessed Feb 2014) .Google ScholarThere is no corresponding record for this reference.
- 13Trott, O.; Olson, A. J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading J. Comput. Chem. 2010, 31, 455– 461Google Scholar13https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O&md5=c6974af8a1235f7aa09918d3e6f70dc4AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingTrott, Oleg; Olson, Arthur J.Journal of Computational Chemistry (2010), 31 (2), 455-461CODEN: JCCHDD; ISSN:0192-8651. (John Wiley & Sons, Inc.)AutoDock Vina, a new program for mol. docking and virtual screening, is presented. AutoDock Vina achieves an approx. 2 orders of magnitude speed-up compared with the mol. docking software previously developed in the authors' lab (AutoDock 4), while also significantly improving the accuracy of the binding mode predictions, judging by the authors' tests on the training set used in AutoDock 4 development. Further speed-up is achieved from parallelism, by using multithreading on multicore machines. AutoDock Vina automatically calcs. the grid maps and clusters the results in a way transparent to the user.
- 14Liao, C.; Sitzmann, M.; Pugliese, A.; Nicklaus, M. C. Software and resources for computational medicinal chemistry Future Med. Chem. 2011, 3, 1057– 1085Google Scholar14https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotVChtbo%253D&md5=d61c625b3af13ee0d7c4804f8b87020eSoftware and resources for computational medicinal chemistryLiao, Chen-Zhong; Sitzmann, Markus; Pugliese, Angelo; Nicklaus, Marc C.Future Medicinal Chemistry (2011), 3 (8), 1057-1085CODEN: FMCUA7; ISSN:1756-8919. (Future Science Ltd.)A review. Computer-aided drug design plays a vital role in drug discovery and development and has become an indispensable tool in the pharmaceutical industry. Computational medicinal chemists can take advantage of all kinds of software and resources in the computer-aided drug design field for the purposes of discovering and optimizing biol. active compds. This article reviews software and other resources related to computer-aided drug design approaches, putting particular emphasis on structure-based drug design, ligand-based drug design, chem. databases and chemoinformatics tools.
- 15Konstanz Information Miner. http://tech.knime.org/cheminformatics-extensions (accessed Feb 2014) .Google ScholarThere is no corresponding record for this reference.
- 16PUG REST. http://pubchem.ncbi.nlm.nih.gov/pug_rest/PUG_REST.html (accessed Feb 2014) .Google ScholarThere is no corresponding record for this reference.
- 17Cincilla, G.; Thormann, M.; Pons, M. Structuring Chemical Space: Similarity-Based Characterization of the PubChem Database Mol. Inf. 2009, 29, 37– 49Google ScholarThere is no corresponding record for this reference.
- 18ChemNProp – Chemical names to properties. http://chemnprop.irbbarcelona.org (accessed Feb 2014) .Google ScholarThere is no corresponding record for this reference.
- 19Vidal, D.; Thormann, M.; Pons, M. LINGO, an efficient holographic text based method to calculate biophysical properties and intermolecular similarities J. Chem. Inf. Model. 2005, 45, 386– 393Google Scholar19https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1yhurk%253D&md5=5b48a3ea9fbdeadf75d424dfd119cd39LINGO, an Efficient Holographic Text Based Method To Calculate Biophysical Properties and Intermolecular SimilaritiesVidal, David; Thormann, Michael; Pons, MiquelJournal of Chemical Information and Modeling (2005), 45 (2), 386-393CODEN: JCISD8; ISSN:1549-9596. (American Chemical Society)SMILES strings are the most compact text based mol. representations. Implicitly they contain the information needed to compute all kinds of mol. structures and, thus, mol. properties derived from these structures. We show that this implicit information can be accessed directly at SMILES string level without the need to apply explicit time-consuming conversion of the SMILES strings into mol. graphs or 3D structures with subsequent 2D or 3D QSPR calcns. Our method is based on the fragmentation of SMILES strings into overlapping substrings of a defined size that we call LINGOs. The integral set of LINGOs derived from a given SMILES string, the LINGO profile, is a hologram of the SMILES representation of the mol. described. LINGO profiles provide input for QSPR models and the calcn. of intermol. similarities at very low computational cost. The octanol/water partition coeff. (LlogP) QSPR model achieved a correlation coeff. R2=0.93, a root-mean-square error RRMS=0.49 log units, a goodness of prediction correlation coeff. Q2=0.89 and a QRMS=0.61 log units. The intrinsic aq. soly. (LlogS) QSPR model achieved correlation coeff. values of R2=0.91, Q2=0.82, and RRMS=0.60 and QRMS=0.89 log units. Integral Tanimoto coeffs. computed from LINGO profiles provided sharp discrimination between random and bioisoster pairs extd. from Accelrys Bioster Database. Av. similarities (LINGOsim) were 0.07 for the random pairs and 0.36 for the bioisosteric pairs.
- 20Morris, G. M.; Huey, R.; Lindstrom, W.; Sanner, M. F.; Belew, R. K.; Goodsell, D. S.; Olson, A. J. Autodock4 and AutoDockTools4: automated docking with selective receptor flexiblity J. Comput. Chem. 2009, 16, 2785– 91Google ScholarThere is no corresponding record for this reference.
- 21Docking At UTMB - DUD Results. http://docking.utmb.edu/dudresults/ (accessed Feb 2014)Google ScholarThere is no corresponding record for this reference.
- 22Irwin, J. J.; Sterling, S.; Mysinger, M. M.; Bolstad, E. S.; Coleman, R. G. ZINC: A Free Tool to Discover Chemistry for Biology J. Chem. Inf. Model. 2012, 52, 1757– 1768Google Scholar22https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvFGnsrg%253D&md5=97f2ede64afc6b5e3ea2f279e38e32a0ZINC: A Free Tool to Discover Chemistry for BiologyIrwin, John J.; Sterling, Teague; Mysinger, Michael M.; Bolstad, Erin S.; Coleman, Ryan G.Journal of Chemical Information and Modeling (2012), 52 (7), 1757-1768CODEN: JCISD8; ISSN:1549-9596. (American Chemical Society)ZINC is a free public resource for ligand discovery. The database contains over twenty million com. available mols. in biol. relevant representations that may be downloaded in popular ready-to-dock formats and subsets. The Web site also enables searches by structure, biol. activity, phys. property, vendor, catalog no., name, and CAS no. Small custom subsets may be created, edited, shared, docked, downloaded, and conveyed to a vendor for purchase. The database is maintained and curated for a high purchasing success rate and is freely available at zinc.docking.org.
- 23Li, H.; Leung, K.-S.; Wong, M.-H. idock: A Multithreaded Virtual Screening Tool for Flexible Ligand Docking Proc. IEEE Symp. Comput. Intell. Bioinf. Comput. Biol. 2012, 77– 84 DOI: 10.1109/CIBCB.2012.6217214Google ScholarThere is no corresponding record for this reference.
- 24DeLano, W. L.; The PyMOL Molecular Graphics System, version 1.5.0.4; Schrodinger: New York, 2002.Google ScholarThere is no corresponding record for this reference.
- 25Calderón Villalobos, L. I. A.; Lee, S.; De Oliveira, C.; Ivetac, A.; Brandt, W.; Armitage, L.; Sheard, L. B.; Tan, X.; Parry, G.; Mao, H.; Zheng, N.; Napier, R.; Kepinski, S.; Estelle, M. A combinatorial TIR1/AFB–Aux/IAA co-receptor system for differential sensing of auxin Nat. Chem. Biol. 2012, 8, 477– 485Google Scholar25https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvVGru7c%253D&md5=04d89cd18f69c796e2486eff71cf195dA combinatorial TIR1/AFB-Aux/IAA co-receptor system for differential sensing of auxinCalderon Villalobos, Luz Irina A.; Lee, Sarah; De Oliveira, Cesar; Ivetac, Anthony; Brandt, Wolfgang; Armitage, Lynne; Sheard, Laura B.; Tan, Xu; Parry, Geraint; Mao, Haibin; Zheng, Ning; Napier, Richard; Kepinski, Stefan; Estelle, MarkNature Chemical Biology (2012), 8 (5), 477-485CODEN: NCBABT; ISSN:1552-4450. (Nature Publishing Group)The plant hormone auxin regulates virtually every aspect of plant growth and development. Auxin acts by binding the F-box protein transport inhibitor response 1 (TIR1) and promotes the degrdn. of the AUXIN/INDOLE-3-ACETIC ACID (Aux/IAA) transcriptional repressors. Here, the authors show that efficient auxin binding requires assembly of an auxin co-receptor complex consisting of TIR1 and an Aux/IAA protein. Heterologous expts. in yeast and quant. IAA binding assays using purified proteins showed that different combinations of TIR1 and Aux/IAA proteins form co-receptor complexes with a wide range of auxin-binding affinities. Auxin affinity seems to be largely detd. by the Aux/IAA. As there are 6 TIR1/AUXIN SIGNALING F-BOX proteins (AFBs) and 29 Aux/IAA proteins in Arabidopsis thaliana, combinatorial interactions may result in many co-receptors with distinct auxin-sensing properties. The authors also demonstrate that the AFB5-Aux/IAA co-receptor selectively binds the auxinic herbicide picloram. This co-receptor system broadens the effective concn. range of the hormone and may contribute to the complexity of auxin response.
Cited By
This article is cited by 13 publications.
- Audrey G. Fikes, Melissa C. Srougi. Design and Implementation of an Accessible and Open-Sourced In Silico Drug Screening Activity for Cancer Drug Discovery. Journal of Chemical Education 2023, 100
(10)
, 4125-4130. https://doi.org/10.1021/acs.jchemed.3c00307
- Bethanie A. Clent, Yuhang Wang, Hugh C. Britton, Frank Otto, Christopher J. Swain, Matthew H. Todd, Jonathan D. Wilden, Alethea B. Tabor. Molecular Docking with Open Access Software: Development of an Online Laboratory Handbook and Remote Workflow for Chemistry and Pharmacy Master’s Students to Undertake Computer-Aided Drug Design. Journal of Chemical Education 2021, 98
(9)
, 2899-2905. https://doi.org/10.1021/acs.jchemed.1c00289
- John G. Hardy, Stephanie Sdepanian, Alison F. Stowell, Amal D. Aljohani, Michael J. Allen, Ayaz Anwar, Dik Barton, John V. Baum, David Bird, Adam Blaney, Liz Brewster, David Cheneler, Olga Efremova, Michael Entwistle, Reza N. Esfahani, Melike Firlak, Alex Foito, Leandro Forciniti, Sydney A. Geissler, Feng Guo, Rania M. Hathout, Richard Jiang, Punarja Kevin, David Leese, Wan Li Low, Sarah Mayes, Masoud Mozafari, Samuel T. Murphy, Hieu Nguyen, Chifundo N. M. Ntola, George Okafo, Adam Partington, Thomas A. K. Prescott, Stephen P. Price, Sherif Soliman, Papri Sutar, David Townsend, Patrick Trotter, Karen L. Wright. Potential for Chemistry in Multidisciplinary, Interdisciplinary, and Transdisciplinary Teaching Activities in Higher Education. Journal of Chemical Education 2021, 98
(4)
, 1124-1145. https://doi.org/10.1021/acs.jchemed.0c01363
- Dean J. Tantillo, Justin B. Siegel, Carla M. Saunders, Teresa A. Palazzo, Phillip P. Painter, Terrence E. O’Brien, Nicole N. Nuñez, Dustin H. Nouri, Michael W. Lodewyk, Brandi M. Hudson, Stephanie R. Hare, Rebecca L. Davis. Computer-Aided Drug Design for Undergraduates. Journal of Chemical Education 2019, 96
(5)
, 920-925. https://doi.org/10.1021/acs.jchemed.8b00712
- Mussa Quareshy, Justyna Prusinska, Martin Kieffer, Kosuke Fukui, Alonso J. Pardal, Silke Lehmann, Patrick Schafer, Charo I. del Genio, Stefan Kepinski, Kenichiro Hayashi, Andrew Marsh, Richard M. Napier. The Tetrazole Analogue of the Auxin Indole-3-acetic Acid Binds Preferentially to TIR1 and Not AFB5. ACS Chemical Biology 2018, 13
(9)
, 2585-2594. https://doi.org/10.1021/acschembio.8b00527
- Aaron R. Van Dyke, Daniel H. Gatazka, and Mariah M. Hanania . Innovations in Undergraduate Chemical Biology Education. ACS Chemical Biology 2018, 13
(1)
, 26-35. https://doi.org/10.1021/acschembio.7b00986
- Travis R. Helgren and Timothy J. Hagen . Demonstration of AutoDock as an Educational Tool for Drug Discovery. Journal of Chemical Education 2017, 94
(3)
, 345-349. https://doi.org/10.1021/acs.jchemed.6b00555
- Antoine Daina, Marie-Claude Blatter, Vivienne Baillie Gerritsen, Patricia M. Palagi, Diana Marek, Ioannis Xenarios, Torsten Schwede, Olivier Michielin, and Vincent Zoete . Drug Design Workshop: A Web-Based Educational Tool To Introduce Computer-Aided Drug Design to the General Public. Journal of Chemical Education 2017, 94
(3)
, 335-344. https://doi.org/10.1021/acs.jchemed.6b00596
- Ricardo P. Rodrigues, Saulo F. Andrade, Susimaire P. Mantoani, Vera L. Eifler-Lima, Vinicius B. Silva, and Daniel F. Kawano . Using Free Computational Resources To Illustrate the Drug Design Process in an Undergraduate Medicinal Chemistry Course. Journal of Chemical Education 2015, 92
(5)
, 827-835. https://doi.org/10.1021/ed500195d
- Piotr Minkiewicz, Anna Iwaniak, and Małgorzata Darewicz . Using Internet Databases for Food Science Organic Chemistry Students To Discover Chemical Compound Information. Journal of Chemical Education 2015, 92
(5)
, 874-876. https://doi.org/10.1021/ed5006739
- Ahmad Sattari, Ali Ramazani, Hamideh Aghahosseini. Repositioning therapeutics for COVID-19: virtual screening of the potent synthetic and natural compounds as SARS-CoV-2 3CLpro inhibitors. Journal of the Iranian Chemical Society 2021, 18
(10)
, 2807-2827. https://doi.org/10.1007/s13738-021-02235-7
- Sheng Zhang, Maj Krumberger, Michael A. Morris, Chelsea Marie T. Parrocha, Adam G. Kreutzer, James S. Nowick. Structure-based drug design of an inhibitor of the SARS-CoV-2 (COVID-19) main protease using free software: A tutorial for students and scientists. European Journal of Medicinal Chemistry 2021, 218 , 113390. https://doi.org/10.1016/j.ejmech.2021.113390
- Rajarshi Guha, Egon Willighagen. Learning cheminformatics. Journal of Cheminformatics 2020, 12
(1)
https://doi.org/10.1186/s13321-019-0406-z
Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.
Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.
The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated.
Recommended Articles
References
This article references 25 other publications.
- 1JCE staff. Computational Chemistry for the Masses. J. Chem. Educ. 1996, 73, 104.There is no corresponding record for this reference.
- 2Manallack, D. T.; Chalmers, D. K.; Yuriev, E. Using the β2-Adrenoceptor for Structure-Based Drug Design J. Chem. Educ. 2010, 87, 625– 627There is no corresponding record for this reference.
- 3Hopkins, A. L. Network pharmacology: the next paradigm in drug discovery Nat. Chem. Biol. 2008, 4, 682– 6903https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Kgs7fK&md5=03b8be3ddbcab7dc65afd17df7ee8395Network pharmacology: the next paradigm in drug discoveryHopkins, Andrew L.Nature Chemical Biology (2008), 4 (11), 682-690CODEN: NCBABT; ISSN:1552-4450. (Nature Publishing Group)A review. The dominant paradigm in drug discovery is the concept of designing maximally selective ligands to act on individual drug targets. However, many effective drugs act via modulation of multiple proteins rather than single targets. Advances in systems biol. are revealing a phenotypic robustness and a network structure that strongly suggests that exquisitely selective compds., compared with multi-target drugs, may exhibit lower than desired clin. efficacy. This new appreciation of the role of polypharmacol. has significant implications for tackling the two major sources of attrition in drug development, efficacy and toxicity. Integrating network biol. and polypharmacol. holds the promise of expanding the current opportunity space for druggable targets. However, the rational design of polypharmacol. faces considerable challenges in the need for new methods to validate target combinations and optimize multiple structure-activity relationships while maintaining drug-like properties. Advances in these areas are creating the foundation of the next paradigm in drug discovery: network pharmacol.
- 4Brown, J. B.; Okuno, Y. Systems biology and systems chemistry: new directions for drug discovery Chem. Biol. 2012, 19, 23– 284https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Ggs78%253D&md5=4caefd47360f8c59ac8ae1a0389298f6Systems Biology and Systems Chemistry: New Directions for Drug DiscoveryBrown, J. B.; Okuno, YasushiChemistry & Biology (Oxford, United Kingdom) (2012), 19 (1), 23-28CODEN: CBOLE2; ISSN:1074-5521. (Elsevier Ltd.)Improvements in drug design have historically been centered around structure-based optimization of mol. specificity for a targeted protein, in an effort to reduce unintentional binding to other proteins and off-target effects. Although the "one-to-one" drug design strategy has been successful in impairing function of targets assocd. with a no. of diseases, recent reports of drug promiscuity, which are a potential source of adverse reactions in patients, make a case to refine the drug design strategy such that it includes an awareness of multiple interactions from both ligand and protein perspectives. Polypharmacol. and chem. biol. studies are amassing interaction data at rapid rates, and the integration of such data into an interpretable model requires zooming our perspective out from the single ligand-target level to the larger network-wide level. We review some of the recent developments in systems-level research for drug design and discovery, and discuss the directions that some drug design efforts are heading toward.
- 5Ortí, L.; Carbajo, R. J.; Pieper, U.; Eswar, N.; Maurer, S. M.; Rai, A. K.; Taylor, G.; Todd, M. H.; Pineda-Lucena, A.; Sali, A.; Marti-Renom, M. A. A Kernel for Open Source Drug Discovery in Tropical Diseases PLoS Neglected Trop. Dis. 2009, 3, e418 DOI: 10.1371/journal.pntd.0000418There is no corresponding record for this reference.
- 6Sutch, B. T.; Romero, R. M.; Neamati, N.; Haworth, I. S. Integrated Teaching of Structure-Based Drug Design and Biopharmaceutics: A Computer-Based Approach J. Chem. Educ. 2012, 89, 45– 51There is no corresponding record for this reference.
- 7Altschul, S. F.; Gish, W.; Miller, W.; Myers, E. W.; Lipman, D. J. Basic local alignment search tool J. Mol. Biol. 1990, 215, 4037https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXitVGmsA%253D%253D&md5=009d2323eb82f0549356880e1101db16Basic local alignment search toolAltschul, Stephen F.; Gish, Warren; Miller, Webb; Myers, Eugene W.; Lipman, David J.Journal of Molecular Biology (1990), 215 (3), 403-10CODEN: JMOBAK; ISSN:0022-2836.A new approach to rapid sequence comparison, basic local alignment search tool (BLAST), directly approximates alignments that optimize a measure of local similarity, the maximal segment pair (MSP) score. Recent math. results on the stochastic properties of MSP scores allow an anal. of the performance of this method as well as the statistical significance of alignments it generates. The basic algorithm is simple and robust; it can be implemented in a no. of ways and applied in a variety of contexts including straightforward DNA and protein sequence database searches, motif searches, gene identification searches, and in the anal. of multiple regions of similarity in long DNA sequences. In addn. to its flexibility and tractability to math. anal., BLAST is an order of magnitude faster than existing sequence comparison tools of comparable sensitivity.
- 8Ekins, S.; Waller, C. L.; Bradley, M. P.; Clark, A. M.; Williams, A. J. Four disruptive strategies for removing drug discovery bottlenecks Drug Discovery Today 2013, 18, 265– 2718https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s%252FotFyktw%253D%253D&md5=eeca13e5dac8f3d04976eeeefe8f46c2Four disruptive strategies for removing drug discovery bottlenecksEkins Sean; Waller Chris L; Bradley Mary P; Clark Alex M; Williams Antony JDrug discovery today (2013), 18 (5-6), 265-71 ISSN:.Drug discovery is shifting focus from industry to outside partners and, in the process, creating new bottlenecks. Technologies like high throughput screening (HTS) have moved to a larger number of academic and institutional laboratories in the USA, with little coordination or consideration of the outputs and creating a translational gap. Although there have been collaborative public-private partnerships in Europe to share pharmaceutical data, the USA has seemingly lagged behind and this may hold it back. Sharing precompetitive data and models may accelerate discovery across the board, while finding the best collaborators, mining social media and mobile approaches to open drug discovery should be evaluated in our efforts to remove drug discovery bottlenecks. We describe four strategies to rectify the current unsustainable situation.
- 9Irwin, J. J.; Shoichet, B. K.; Mysinger, M. M.; Huang, N.; Francesco Colizzi, F.; Wassam, P.; Cao, Yiqun. Automated Docking Screens: A Feasibility Study J. Med. Chem. 2009, 52, 5712– 57209https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVOjurjN&md5=f302db1f77b87f26d1fa2fece55bca96Automated Docking Screens: A Feasibility StudyIrwin, John J.; Shoichet, Brian K.; Mysinger, Michael M.; Huang, Niu; Colizzi, Francesco; Wassam, Pascal; Cao, YiqunJournal of Medicinal Chemistry (2009), 52 (18), 5712-5720CODEN: JMCMAR; ISSN:0022-2623. (American Chemical Society)Mol. docking is the most practical approach to leverage protein structure for ligand discovery, but the technique retains important liabilities that make it challenging to deploy on a large scale. We have therefore created an expert system, DOCK Blaster, to investigate the feasibility of full automation. The method requires a PDB code, sometimes with a ligand structure, and from that alone can launch a full screen of large libraries. A crit. feature is self-assessment, which ests. the anticipated reliability of the automated screening results using pose fidelity and enrichment. Against common benchmarks, DOCK Blaster recapitulates the crystal ligand pose within 2 Å rmsd 50-60% of the time; inferior to an expert, but respectable. Half the time the ligand also ranked among the top 5% of 100 phys. matched decoys chosen on the fly. Further tests were undertaken culminating in a study of 7755 eligible PDB structures. In 1398 cases, the redocked ligand ranked in the top 5% of 100 property-matched decoys while also posing within 2 Å rmsd, suggesting that unsupervised prospective docking is viable. DOCK Blaster is available at http://blaster.docking.org.
- 10Gaulton, A.; Bellis, L. J.; Bento, A. P.; Chambers, J.; Davies, M.; Hersey, A.; Light, Y.; McGlinchey, S.; Michalovich, D.; Al-Lazikani, B.; Overington, J. P. ChEMBL: a large-scale bioactivity database for drug discovery Nucleic Acids Res. 2011, 40, 1100– 1107There is no corresponding record for this reference.
- 11O’Boyle, N. M.; Banck, M.; James, C. A.; Morley, C.; Vandermeersch, T.; Hutchison, G. R. Open Babel: An open chemical toolbox J. Cheminf. 2011, 3, 33 DOI: 10.1186/1758-2946-3-3311https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVWjurbF&md5=74e4f19b7f87417f916d57f7abcfb761Open Babel: an open chemical toolboxO'Boyle, Noel M.; Banck, Michael; James, Craig A.; Morley, Chris; Vandermeersch, Tim; Hutchison, Geoffrey R.Journal of Cheminformatics (2011), 3 (), 33CODEN: JCOHB3; ISSN:1758-2946. (Chemistry Central Ltd.)Background: A frequent problem in computational modeling is the interconversion of chem. structures between different formats. While std. interchange formats exist (for example, Chem. Markup Language) and de facto stds. have arisen (for example, SMILES format), the need to interconvert formats is a continuing problem due to the multitude of different application areas for chem. data, differences in the data stored by different formats (0D vs. 3D, for example), and competition between software along with a lack of vendor-neutral formats. Results: We discuss, for the first time, Open Babel, an open-source chem. toolbox that speaks the many languages of chem. data. Open Babel version 2.3 interconverts over 110 formats. The need to represent such a wide variety of chem. and mol. data requires a library that implements a wide range of cheminformatics algorithms, from partial charge assignment and aromaticity detection, to bond order perception and canonicalization. We detail the implementation of Open Babel, describe key advances in the 2.3 release, and outline a variety of uses both in terms of software products and scientific research, including applications far beyond simple format interconversion. Conclusions: Open Babel presents a soln. to the proliferation of multiple chem. file formats. In addn., it provides a variety of useful utilities from conformer searching and 2D depiction, to filtering, batch conversion, and substructure and similarity searching. For developers, it can be used as a programming library to handle chem. data in areas such as org. chem., drug design, materials science, and computational chem. It is freely available under an open-source license.
- 12The Open Babel Package, version 2.3.1. http://openbabel.org (accessed Feb 2014) .There is no corresponding record for this reference.
- 13Trott, O.; Olson, A. J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading J. Comput. Chem. 2010, 31, 455– 46113https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O&md5=c6974af8a1235f7aa09918d3e6f70dc4AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingTrott, Oleg; Olson, Arthur J.Journal of Computational Chemistry (2010), 31 (2), 455-461CODEN: JCCHDD; ISSN:0192-8651. (John Wiley & Sons, Inc.)AutoDock Vina, a new program for mol. docking and virtual screening, is presented. AutoDock Vina achieves an approx. 2 orders of magnitude speed-up compared with the mol. docking software previously developed in the authors' lab (AutoDock 4), while also significantly improving the accuracy of the binding mode predictions, judging by the authors' tests on the training set used in AutoDock 4 development. Further speed-up is achieved from parallelism, by using multithreading on multicore machines. AutoDock Vina automatically calcs. the grid maps and clusters the results in a way transparent to the user.
- 14Liao, C.; Sitzmann, M.; Pugliese, A.; Nicklaus, M. C. Software and resources for computational medicinal chemistry Future Med. Chem. 2011, 3, 1057– 108514https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotVChtbo%253D&md5=d61c625b3af13ee0d7c4804f8b87020eSoftware and resources for computational medicinal chemistryLiao, Chen-Zhong; Sitzmann, Markus; Pugliese, Angelo; Nicklaus, Marc C.Future Medicinal Chemistry (2011), 3 (8), 1057-1085CODEN: FMCUA7; ISSN:1756-8919. (Future Science Ltd.)A review. Computer-aided drug design plays a vital role in drug discovery and development and has become an indispensable tool in the pharmaceutical industry. Computational medicinal chemists can take advantage of all kinds of software and resources in the computer-aided drug design field for the purposes of discovering and optimizing biol. active compds. This article reviews software and other resources related to computer-aided drug design approaches, putting particular emphasis on structure-based drug design, ligand-based drug design, chem. databases and chemoinformatics tools.
- 15Konstanz Information Miner. http://tech.knime.org/cheminformatics-extensions (accessed Feb 2014) .There is no corresponding record for this reference.
- 16PUG REST. http://pubchem.ncbi.nlm.nih.gov/pug_rest/PUG_REST.html (accessed Feb 2014) .There is no corresponding record for this reference.
- 17Cincilla, G.; Thormann, M.; Pons, M. Structuring Chemical Space: Similarity-Based Characterization of the PubChem Database Mol. Inf. 2009, 29, 37– 49There is no corresponding record for this reference.
- 18ChemNProp – Chemical names to properties. http://chemnprop.irbbarcelona.org (accessed Feb 2014) .There is no corresponding record for this reference.
- 19Vidal, D.; Thormann, M.; Pons, M. LINGO, an efficient holographic text based method to calculate biophysical properties and intermolecular similarities J. Chem. Inf. Model. 2005, 45, 386– 39319https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1yhurk%253D&md5=5b48a3ea9fbdeadf75d424dfd119cd39LINGO, an Efficient Holographic Text Based Method To Calculate Biophysical Properties and Intermolecular SimilaritiesVidal, David; Thormann, Michael; Pons, MiquelJournal of Chemical Information and Modeling (2005), 45 (2), 386-393CODEN: JCISD8; ISSN:1549-9596. (American Chemical Society)SMILES strings are the most compact text based mol. representations. Implicitly they contain the information needed to compute all kinds of mol. structures and, thus, mol. properties derived from these structures. We show that this implicit information can be accessed directly at SMILES string level without the need to apply explicit time-consuming conversion of the SMILES strings into mol. graphs or 3D structures with subsequent 2D or 3D QSPR calcns. Our method is based on the fragmentation of SMILES strings into overlapping substrings of a defined size that we call LINGOs. The integral set of LINGOs derived from a given SMILES string, the LINGO profile, is a hologram of the SMILES representation of the mol. described. LINGO profiles provide input for QSPR models and the calcn. of intermol. similarities at very low computational cost. The octanol/water partition coeff. (LlogP) QSPR model achieved a correlation coeff. R2=0.93, a root-mean-square error RRMS=0.49 log units, a goodness of prediction correlation coeff. Q2=0.89 and a QRMS=0.61 log units. The intrinsic aq. soly. (LlogS) QSPR model achieved correlation coeff. values of R2=0.91, Q2=0.82, and RRMS=0.60 and QRMS=0.89 log units. Integral Tanimoto coeffs. computed from LINGO profiles provided sharp discrimination between random and bioisoster pairs extd. from Accelrys Bioster Database. Av. similarities (LINGOsim) were 0.07 for the random pairs and 0.36 for the bioisosteric pairs.
- 20Morris, G. M.; Huey, R.; Lindstrom, W.; Sanner, M. F.; Belew, R. K.; Goodsell, D. S.; Olson, A. J. Autodock4 and AutoDockTools4: automated docking with selective receptor flexiblity J. Comput. Chem. 2009, 16, 2785– 91There is no corresponding record for this reference.
- 21Docking At UTMB - DUD Results. http://docking.utmb.edu/dudresults/ (accessed Feb 2014)There is no corresponding record for this reference.
- 22Irwin, J. J.; Sterling, S.; Mysinger, M. M.; Bolstad, E. S.; Coleman, R. G. ZINC: A Free Tool to Discover Chemistry for Biology J. Chem. Inf. Model. 2012, 52, 1757– 176822https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvFGnsrg%253D&md5=97f2ede64afc6b5e3ea2f279e38e32a0ZINC: A Free Tool to Discover Chemistry for BiologyIrwin, John J.; Sterling, Teague; Mysinger, Michael M.; Bolstad, Erin S.; Coleman, Ryan G.Journal of Chemical Information and Modeling (2012), 52 (7), 1757-1768CODEN: JCISD8; ISSN:1549-9596. (American Chemical Society)ZINC is a free public resource for ligand discovery. The database contains over twenty million com. available mols. in biol. relevant representations that may be downloaded in popular ready-to-dock formats and subsets. The Web site also enables searches by structure, biol. activity, phys. property, vendor, catalog no., name, and CAS no. Small custom subsets may be created, edited, shared, docked, downloaded, and conveyed to a vendor for purchase. The database is maintained and curated for a high purchasing success rate and is freely available at zinc.docking.org.
- 23Li, H.; Leung, K.-S.; Wong, M.-H. idock: A Multithreaded Virtual Screening Tool for Flexible Ligand Docking Proc. IEEE Symp. Comput. Intell. Bioinf. Comput. Biol. 2012, 77– 84 DOI: 10.1109/CIBCB.2012.6217214There is no corresponding record for this reference.
- 24DeLano, W. L.; The PyMOL Molecular Graphics System, version 1.5.0.4; Schrodinger: New York, 2002.There is no corresponding record for this reference.
- 25Calderón Villalobos, L. I. A.; Lee, S.; De Oliveira, C.; Ivetac, A.; Brandt, W.; Armitage, L.; Sheard, L. B.; Tan, X.; Parry, G.; Mao, H.; Zheng, N.; Napier, R.; Kepinski, S.; Estelle, M. A combinatorial TIR1/AFB–Aux/IAA co-receptor system for differential sensing of auxin Nat. Chem. Biol. 2012, 8, 477– 48525https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvVGru7c%253D&md5=04d89cd18f69c796e2486eff71cf195dA combinatorial TIR1/AFB-Aux/IAA co-receptor system for differential sensing of auxinCalderon Villalobos, Luz Irina A.; Lee, Sarah; De Oliveira, Cesar; Ivetac, Anthony; Brandt, Wolfgang; Armitage, Lynne; Sheard, Laura B.; Tan, Xu; Parry, Geraint; Mao, Haibin; Zheng, Ning; Napier, Richard; Kepinski, Stefan; Estelle, MarkNature Chemical Biology (2012), 8 (5), 477-485CODEN: NCBABT; ISSN:1552-4450. (Nature Publishing Group)The plant hormone auxin regulates virtually every aspect of plant growth and development. Auxin acts by binding the F-box protein transport inhibitor response 1 (TIR1) and promotes the degrdn. of the AUXIN/INDOLE-3-ACETIC ACID (Aux/IAA) transcriptional repressors. Here, the authors show that efficient auxin binding requires assembly of an auxin co-receptor complex consisting of TIR1 and an Aux/IAA protein. Heterologous expts. in yeast and quant. IAA binding assays using purified proteins showed that different combinations of TIR1 and Aux/IAA proteins form co-receptor complexes with a wide range of auxin-binding affinities. Auxin affinity seems to be largely detd. by the Aux/IAA. As there are 6 TIR1/AUXIN SIGNALING F-BOX proteins (AFBs) and 29 Aux/IAA proteins in Arabidopsis thaliana, combinatorial interactions may result in many co-receptors with distinct auxin-sensing properties. The authors also demonstrate that the AFB5-Aux/IAA co-receptor selectively binds the auxinic herbicide picloram. This co-receptor system broadens the effective concn. range of the hormone and may contribute to the complexity of auxin response.
Supporting Information
Supporting Information
A straightforward protocol written in Python that depends on Open Babel being installed is available. Vina is also provided, but if an installed version is found, that is used in preference. The code is commented and will be maintained and updated through www.opendiscovery.org.uk. This material is available via the Internet at http://pubs.acs.org.
Terms & Conditions
Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: http://pubs.acs.org/page/copyright/permissions.html.